National Presto Subsidiary Secures $119.8M U.S. Army Contract for Ammunition Production
NPK sits 78% above its 52-week low of $77.63 on elevated volume (2.3× avg).
Summary
National Presto Industries' subsidiary, AMTEC Corporation, secured a $119.8 million U.S. Army contract for 40mm ammunition production, significantly boosting its Defense segment.
Key Events · M&A and Partnerships · NPK
-
Major Defense Contract Awarded
AMTEC Corporation, a wholly owned subsidiary within National Defense Corporation, received a $119.8 million Indefinite Delivery Indefinite Quantity (IDIQ) contract from the U.S. Army.
-
Significant Revenue Opportunity
The contract is for the production of 40mm M918E2 High Velocity Target Practice – Day / Night / Thermal (TP-DNT) cartridges, providing a substantial boost to the company's Defense segment.
-
Reinforces Defense Segment Strength
This award reinforces the strong performance of the Defense segment, which was a highlight in the company's recent 10-K despite an overall decline in net earnings.
-
Deliveries Scheduled
Deliveries under this new delivery order are expected to commence in late 2027.
Analysis · NPK · Manufacturing
National Presto Industries' wholly owned subsidiary, AMTEC Corporation, has been awarded a significant $119.8 million Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Army. This contract for 40mm M918E2 High Velocity Target Practice cartridges represents a substantial revenue opportunity for the company's Defense segment. This award is particularly impactful given the company's recent 10-K filing, which reported a 20.2% drop in 2025 net earnings, primarily due to weakness in other segments, while the Defense segment was noted for its strength. This new contract reinforces the positive outlook for the Defense segment and provides a strong positive catalyst for the company's future performance, with deliveries expected to commence in late 2027.
At the time of this filing, NPK was trading at $137.95 on NYSE in the Manufacturing sector, with a market capitalization of approximately $988.3M. The 52-week trading range was $77.63 to $149.86. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.